Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NanoViricides Inc.

www.nanoviricides.com

Latest From NanoViricides Inc.

Appointments: BMS CCO Leaves, New Medical Heads At Astellas Americas, Epizyme, CEOs At NanoViricides, Aeglea, Waverley Pharma

Bristol-Myers Squibb's CCO Murdo Gordon has exited the company in the week of its Q2 results, while Trevi Therapeutics, Turnstone Biologics, Aeglea BioTherapeutics, Acadia Pharmaceuticals, NanoViricides and Waverley Pharmaceuticals add to their C-suite. Medical heads join Epizyme and Astellas Americas.

Appointments BioPharmaceutical

Pilgrimage And Pipeline: MERS Prospects

The renewed break-out of a frighteningly deadly virus with no known cure or vaccine in a region that will shortly host a couple of million international pilgrims has prompted a rash of recent headlines linking Middle East Respiratory Syndrome (MERS), the SARS-like coronavirus that first emerged in Saudi Arabia in 2012, and the annual Hajj to Mecca.

Infectious Diseases Neurology

AbbVie/United Therapeutics $350m Voucher Deal: Smart Move?

AbbVie became the latest firm to test the FDA "voucher" strategy as a pathway to success – entering into a $350m deal with United Therapeutics in an effort to get an experimental medicine to the market quicker.

Metabolic Disorders Infectious Diseases

Ebola – the industry's response in antivirals

The unprecedented scale of the Ebola epidemic in West Africa has prompted a similarly unprecedented interest in the response from the pharma and biotech industries to develop treatments and vaccines against the virus.

Cardiovascular Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NanoViricides Inc.
  • Senior Management
  • Eugene Seymour, MD, CEO
    Meeta Vyas, Interim CFO
    Anil R Diwan, Chmn. & Pres.
    Randall Barton, PhD, CSO
    Jayant Tatake, PhD, VP, R&D
  • Contact Info
  • NanoViricides Inc.
    Phone: (203) 937-6137
    135 Wood St., Ste. 205
    West Haven, CT 06516
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register